Ventricular assist device

Results from Magenta Medical's US Early Feasibility Study of the World's Smallest and Most Powerful Heart Pump to be Highlighted at TCT 2023

Retrieved on: 
Tuesday, October 10, 2023
Coronary artery disease, Mount Sinai Hospital (Manhattan), Percutaneous coronary intervention, Safety, Hospital, Teaching hospital, Diagnosis, Cardiology, Mount Sinai Hospital, Magenta, Ventricular assist device, Interventional cardiology, Philippine Heart Center, North Shore University Hospital, St. Francis Hospital, TCT, Patient, Pharmaceutical industry, Medical device

KADIMA, Israel , Oct. 10, 2023 /PRNewswire/ --Results from Magenta Medical's Early Feasibility Study of the Elevate™ System, for the high-risk percutaneous coronary intervention (HR-PCI) indication, will be announced in an oral presentation at the Transcatheter Cardiovascular Therapeutics (TCT) conference, the annual scientific symposium of the Cardiovascular Research Foundation in San Francisco. Elevate™ is the world's smallest and most powerful percutaneous Left Ventricular Assist Device (pLVAD).

Key Points: 
  • Elevate™ is the world's smallest and most powerful percutaneous Left Ventricular Assist Device (pLVAD).
  • Presentation title: Magenta Elevate™: First US Experience with High-Output, Low-French Size Percutaneous Mechanical Circulatory Support
    Session: TCT Innovation V: Innovation in Coronary Disease Diagnosis and Therapies/Featured Technological Trends: Percutaneous Mechanical Circulatory Support.
  • Magenta's US Early Feasibility Study was initiated to evaluate the safety and feasibility of the Elevate™ System in providing temporary mechanical circulatory support during HR-PCI procedures.
  • Fifteen patients were treated in the study at the Mount Sinai Hospital, St. Francis Hospital and Heart Center, and North Shore University Hospital.

Cardiost, Inc. Strengthens Scientific Advisory Board with Renowned Cardiovascular Experts, Advances Prototype Development with OEDIT Grant Support

Retrieved on: 
Friday, September 29, 2023
Medical device, University, Heart failure, Interventional cardiology, Lung transplantation, HF, Johnson & Johnson, Clinical trial, Coronavirus Scientific Advisory Board, Research, The Journal of Heart and Lung Transplantation, Biomedical engineering, Universidad, PCI, Harvard Medical School, IMACS, University of Los Andes (Colombia), CO, Journal, Wallace H. Coulter Department of Biomedical Engineering, User experience, Mount Sinai Medical Center, Publication, Biomedicine, MD, Montefiore Medical Center, Cardiology, Universidad de los Andes, Internal medicine, Fort Collins, Colorado, Journal of Cardiac Surgery, LVAD, Ventricular assist device, Hospital, MCS, Massachusetts General Hospital, CFD, Pharmaceutical industry, Heart, Patient

Cardiost is currently designing an alpha prototype of its LAUD, or Left Atrium Unloading Device, with money it received from Colorado’s OEDIT grant in early 2023.

Key Points: 
  • Cardiost is currently designing an alpha prototype of its LAUD, or Left Atrium Unloading Device, with money it received from Colorado’s OEDIT grant in early 2023.
  • The LAUD is a durable mechanical circulatory support (MCS) device to treat late-stage patients suffering from heart failure (HF).
  • Cardiost is focused on developing cardiovascular devices medical devices in the cardiovascular space.
  • “We are thrilled to add Dr. Goldstein and Dr. Moreno to our Scientific Advisory Board, both KOLs in their respective fields – MCS the former and PCI the latter.

Smarter Tech for Safer Roads: AWP Safety to Showcase Intelligent Traffic Control Solutions at The Utility Expo

Retrieved on: 
Wednesday, September 20, 2023
Afade language, Uncertainty, AWP, Accident, Workplace, Utility, Ventricular assist device, Ludewig, Intelligent transportation system, Documentation, ITS, Mobile phone, Safety

Smart work zones increase safety and efficiency for utility construction projects, and AWP is leading the charge when it comes to protecting both workers and drivers.

Key Points: 
  • Smart work zones increase safety and efficiency for utility construction projects, and AWP is leading the charge when it comes to protecting both workers and drivers.
  • According to Mark Ludewig, Vice President of Safety for AWP Safety, "The data clearly shows that traffic technologies help people reach their destinations safely.
  • Utility Expo attendees can visit booth #S5013 to witness the practical application of smart work zone solutions.
  • They also help refine future traffic control strategies by tracking traffic speed and patterns with camera-equipped cones and barrels.

National Winners of Ingenious+ Youth Innovation Challenge

Retrieved on: 
Thursday, May 11, 2023
Well, Civic, Canada, Climate, Ventricular assist device, Partnership, National Arts Centre, Caregiver, JA, Movement disorder, Social support, Paratriathlon, Health, CIW, Rideau Hall Foundation, Climate change, Equity, Creativity, Community, RHF, Ingenious, Inclusion, Ageing, Ecosystem, Patient, Salt, Environment, Disability, Climate change mitigation framework, Entertainment

OTTAWA, ON, May 11, 2023 /CNW/ - The Rideau Hall Foundation (RHF), in partnership with JA Canada, is pleased to announce the national winners of the 2023 Ingenious+ youth innovation challenge.

Key Points: 
  • OTTAWA, ON, May 11, 2023 /CNW/ - The Rideau Hall Foundation (RHF), in partnership with JA Canada, is pleased to announce the national winners of the 2023 Ingenious+ youth innovation challenge.
  • Young innovators have the opportunity to win regional and national monetary awards and mentorship opportunities, which are supported by an ecosystem of innovation champions.
  • The national winners will be celebrated during Canadian Innovation Week #CIW (May 15th to 19th) on May 18th with an awards ceremony held at the National Arts Centre.
  • The national winners will receive $10,000 and mentorship opportunities to take their innovations to the next stage.

Prevent 300,000 Fall-Related Hospitalizations with Simple Aging in Place Home Modifications According to Lisa M. Cini

Retrieved on: 
Monday, May 8, 2023
Online Retail, Other Health, Other Consumer, Women, Interior Design, Seniors, Men, Medical Devices, Hospitals, Family, Home Goods, Fitness & Nutrition, Consumer, Other Construction & Property, Residential Building & Real Estate, Sports, Other Retail, Construction & Property, Physical Therapy, Managed Care, Health, General Health, Specialty, Building Systems, Baby Boomers, Other Technology, Retail, Other Professional Services, Consulting, Medical Supplies, Consumer Electronics, Technology, Other Sports, Professional Services, Parenting, Blood pressure, Exercise, Cognition, Cini, Mental toughness, Noise, Pilates, Arthritis, AARP, Livewell, Hip, Alexa, Calendar, Ageing, Falls, Ventricular assist device, FIA ecoRally Cup, Movement, CDC, Great Beds Light, Garden, Motion, Dizziness, NASA, Echo, Yoga, Risk, Water, Contempo, Amnesia, Joint, Weather, Falling, Caregiver, Safety, Rain, Hatton Garden safe deposit burglary, Health insurance

However, less than 60 percent have considered the home modifications necessary to safely age in place.

Key Points: 
  • However, less than 60 percent have considered the home modifications necessary to safely age in place.
  • America’s leading aging expert Lisa M. Cini has compiled a list of simple home modifications to prevent falling, maintain balance while they remain in their homes.
  • “Taking these few easy steps to make your living space safer will help you avoid falls and stay independent for longer in your home,” says Cini.
  • “Adopting technology is essential to helping aging adults prevent falls, maintaining their independence and quality of life.”

Aiosyn, Pathomation, and Radboud University Medical Center Are Awarded 1,6M € Eurostars Grant to Develop AI-Powered Solutions for Renal Diagnostics

Retrieved on: 
Wednesday, April 5, 2023
Other Health, Software, Research, General Health, Technology, Artificial Intelligence, Genetics, Health Technology, Clinical Trials, Science, Biotechnology, Health, Workflow, Nijmegen, CSO, RRT, Marie Cassidy, Pathology, Kidney, Dialysis, Radboud University Medical Center, Radbod, Ventricular assist device, Patient, IMS, Kidney transplantation, Quality control, AI, Chronic kidney disease, CKD, EuroSTAR Conference, Biopsy, Medical device, Medical imaging, Nakhon Pathom Hospital, AWAKE

Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a 1,6M € Eurostars grant together with Pathomation and Radboud university medical center to accelerate the development of a Kidney-AI algorithm suite.

Key Points: 
  • Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a 1,6M € Eurostars grant together with Pathomation and Radboud university medical center to accelerate the development of a Kidney-AI algorithm suite.
  • The AWAKE (AI-powered Workflow for Assisted KidnEy diagnostics) project will bring the first AI-powered solution for renal diagnostics and clinical trials to market.
  • In the final stage of CKD, there is a need for renal replacement therapies (RRT) such as dialysis or kidney transplantation.
  • The AI-powered solution will aim to provide major progress in the assessment and disease management of kidney transplant patients worldwide.

Consensus Statement Released by Heart Failure Society of America Offers Best Practices on the Medical Management of Patients on Durable Mechanical Circulatory Support

Retrieved on: 
Wednesday, February 22, 2023
GIB, RVF, GDMT, Health, Blood, LVAD, Patient, Pulmonary hypertension, Heart, Ventricular assist device, Risk, Warfarin, Stroke, Survival, Congestion, Education, Arrhythmia, MCS, Quality of life, Heart failure, MD, Pharmaceutical industry, Medical device, RV

However, proficient medical management of patients on durable LVAD support is necessary to increase their quantity and quality of life," said Barry Trachtenberg, MD lead author and Cardiologist at Houston Methodist Heart and Vascular Center.

Key Points: 
  • However, proficient medical management of patients on durable LVAD support is necessary to increase their quantity and quality of life," said Barry Trachtenberg, MD lead author and Cardiologist at Houston Methodist Heart and Vascular Center.
  • "This consensus statement will provide clinicians with practical information they need to make decisions and support optimal patient care for the management of this unique population."
  • As patients live longer on LVAD support, attention to the medical management of patients on durable LVAD support is paramount for advancing long-term outcomes.
  • Patient education about nutritional and herbal therapies is important to reduce the potential for interference with anticoagulant and antiplatelet management.

United Kingdom Bariatric Surgical Devices Market Report 2022: Implantable Devices v/s Assisting Devices - Competition, Forecast & Opportunities, 2017-2027 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 27, 2023
Surgery, Health, Medical Devices, Stomach, Sleeve, Internal bleeding, Smoking, Ventricular assist device, SG, Investment, Bypass surgery, Procedure, Obesity, Research, Roux-en-Y anastomosis, FDA, Growth, Surgeon, Medical device, Dentistry

The "United Kingdom Bariatric Surgical Devices Market, By Type (Implantable Devices v/s Assisting Devices), By Procedure, By End User, By Region, Competition Forecast & Opportunities, 2017-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United Kingdom Bariatric Surgical Devices Market, By Type (Implantable Devices v/s Assisting Devices), By Procedure, By End User, By Region, Competition Forecast & Opportunities, 2017-2027" report has been added to ResearchAndMarkets.com's offering.
  • The availability of surgeons specializing in bariatric surgical techniques and the growing rate of childhood obesity is anticipated to fuel the growth of the United Kingdom bariatric surgical devices market.
  • To estimate and forecast the market size of United Kingdom bariatric surgical devices market from 2022E to 2027F and growth rate until 2027F.
  • To classify and forecast the United Kingdom bariatric surgical devices market based on type, procedure, end user, region, and company.

UAE Bariatric Surgical Devices Markets, Competition, Forecast & Opportunities, 2017-2022 & 2023-2027 - Implantable Devices {Gastric Bands, Electrical Stimulators, Gastric Balloons - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 26, 2023
Medical Devices, Health, Procedure, Growth, Diagnosis, Mouth, Gastric electrical stimulation, Ventricular assist device, Medical device, Semiconductor, Dentistry

The "UAE Bariatric Surgical Devices Market, By Type (Implantable Devices {Gastric Bands, Electrical Stimulators, Gastric Balloons, Others} v/s Assisting Devices), By Procedure, By End User, By Region, Competition Forecast & Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "UAE Bariatric Surgical Devices Market, By Type (Implantable Devices {Gastric Bands, Electrical Stimulators, Gastric Balloons, Others} v/s Assisting Devices), By Procedure, By End User, By Region, Competition Forecast & Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering.
  • UAE bariatric surgical devices market is anticipated to register a steady growth in the forecast period, 2023-2027
    The growing demand for medical devices for diagnostics and treatment purposes of bariatric surgeries and the rise in the number of bariatric surgeries are the primary drivers for the UAE bariatric surgical devices market.
  • Increasing demand for quick healing and efficient surgeries aid the demand for minimally invasive surgical devices, thereby supporting the growth of the UAE bariatric surgical devices market in the next five years.
  • To classify and forecast the UAE bariatric surgical devices market based on type, procedure, application, region, and company.

Rexlemestrocel-L to be Highlighted at Maxim’s Panel on Late-Stage Advancements in Heart Failure Therapeutics and Management

Retrieved on: 
Tuesday, July 12, 2022
Private Securities Litigation Reform Act, LVAD, LinkedIn, FDA, MESO, Infarction, New York Heart Association Functional Classification, GLOBE, Twitter, Ventricular assist device, Survival, Cardiology, Arrest, Mortality, Therapy, MSB, Food and Drug Administration, Inflammation, Quality, Australian Securities Exchange, Marketing, Mesoblast, Heart failure, Technology, Patient, SEC, Death, Incidence, Orphan drug, Randomized controlled trial, Heart, CHF, Webcast, Food, Chief, Company, Forward-looking statement, Prevalence, European Society of Cardiology, Immune system, SGLT2, Anjan Chatterjee (neuroscientist), Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project, Industry, Risk, Stroke, Hospital-acquired pneumonia, BLA, Pharmaceutical industry, Medical device, NYHA

Heart failure affects approximately 6.5 million people in the United States and 26 million people globally, with increasing prevalence and incidence.

Key Points: 
  • Heart failure affects approximately 6.5 million people in the United States and 26 million people globally, with increasing prevalence and incidence.
  • Mesoblast has a strong and extensive global intellectual property portfolio with protection extending through to at least 2041 in all major markets.
  • Rexlemestrocel-L is in development for advanced chronic heart failure and chronic low back pain.
  • Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes.